Kenvue Inc. to Issue Quarterly Dividend of $0.21 (NYSE:KVUE)
by Teresa Graham · The Cerbat GemKenvue Inc. (NYSE:KVUE – Get Free Report) announced a quarterly dividend on Thursday, September 10th. Stockholders of record on Monday, September 21st will be paid a dividend of 0.21 per share on Friday, October 2nd. This represents a c) annualized dividend and a dividend yield of 4.7%. The ex-dividend date of this dividend is Monday, September 21st.
Kenvue has a dividend payout ratio of 68.9% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Kenvue to earn $1.23 per share next year, which means the company should continue to be able to cover its $0.84 annual dividend with an expected future payout ratio of 68.3%.
Kenvue Stock Up 0.1%
KVUE opened at $17.77 on Friday. The firm has a market cap of $34.14 billion, a price-to-earnings ratio of 20.43, a PEG ratio of 1.58 and a beta of 0.46. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.71 and a current ratio of 1.01. The firm’s 50-day simple moving average is $19.09 and its 200-day simple moving average is $18.24. Kenvue has a twelve month low of $14.02 and a twelve month high of $20.13.
Kenvue (NYSE:KVUE – Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.31 EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). The firm had revenue of $3.96 billion during the quarter, compared to analyst estimates of $3.97 billion. Kenvue had a net margin of 10.76% and a return on equity of 21.22%. Kenvue’s quarterly revenue was up 3.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.29 earnings per share. Equities research analysts anticipate that Kenvue will post 1.14 EPS for the current fiscal year.
About Kenvue
Kenvue Inc is a global consumer health company that develops, markets and sells products designed to support everyday health and personal care. Its portfolio spans over-the-counter medicines, skin health and beauty, essential health products, and baby and family care.
The company’s brands include Tylenol, Motrin, Zyrtec and Benadryl in self-care; Neutrogena, Aveeno and Clean & Clear in skin health and beauty; Listerine in oral care; and Johnson’s and Band-Aid in baby care and essential health.
See Also
- Five stocks we like better than Kenvue
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle